RG
Regencell Bioscience
RGC · NASDAQ
$6.20 +0.16% (+$0.01)
1M +11.98%
Market Cap $3.07B
P/E Ratio -
Div. Yield -
ROE 68.23%
Bulios Fair Price
$4.43
28.5% downside
Trenutna cena
$6.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RGC trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 632.05x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 34.21%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 69.75%
Asset turnover 0.00x
ROE 68.23%
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 7.39x
Int. coverage N/A
Stability
58 /100
Moderate Beta 1.43x
Profitable years 0
EPS volatility 4.89%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RGC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yat-Gai Au
Employees
10
Headquarters
Hong Kong
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report